VDR and tuberculosis: The current study provides new and innovative data supporting the hypothesis that TB-driven single MIR337-3p species could specifically target/impair both TLR4/MYD88 and STAT3 activation signals, inhibiting VDR-activated antimicrobial response and fast-acting anti-TB immunity, leading to enhanced pathogenicity (Figure 8F).